NeuroPace Inc (NPCE): Next-Year EPS Estimate 45.66%
As of 2026-06-11, NeuroPace Inc (NPCE) has a next-year EPS growth estimate of 45.66%.
On 2026-06-09, analyst consensus for NPCE's next-year EPS growth shifted from 47.49% to 45.66% — a negative change of 1.83 percentage points. The revised estimate has been sustained across 3 subsequent trading sessions. Current-year growth is projected at 6.85%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 45.66%
- EPS growth this year
- 6.85%
- EPS next quarter (est)
- -$0.21
- Last price
- $15.84
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 45.66% | 6.85% | -$0.21 | $15.84 |
| 2026-06-10 | 45.66% | 6.85% | -$0.21 | $15.71 |
| 2026-06-09 | 45.66% | 6.85% | -$0.21 | $15.96 |
| 2026-06-08 | 47.49% | 12.11% | -$0.21 | $15.63 |
| 2026-06-07 | 47.49% | 12.11% | -$0.21 | $15.74 |
| 2026-06-04 | 47.49% | 12.11% | -$0.21 | $16.32 |
| 2026-06-03 | 47.49% | 12.11% | -$0.21 | $15.88 |
| 2026-06-02 | 47.49% | 12.11% | -$0.21 | $16.29 |
| 2026-06-01 | 47.49% | 12.11% | -$0.21 | $16.51 |
| 2026-05-31 | 47.49% | 12.11% | -$0.21 | $16.54 |
| 2026-05-28 | 47.49% | 12.11% | -$0.21 | $17.39 |
| 2026-05-27 | 47.49% | 12.11% | -$0.21 | $17.06 |
| 2026-05-26 | 47.49% | 12.11% | -$0.21 | $16.68 |
| 2026-05-25 | 47.49% | 12.11% | -$0.21 | $16.92 |
| 2026-05-24 | 47.49% | 12.11% | -$0.21 | $16.92 |
| 2026-05-21 | 47.49% | 12.11% | -$0.21 | $16.28 |
| 2026-05-20 | 47.49% | 12.11% | -$0.21 | $16.27 |
| 2026-05-19 | 47.49% | 12.11% | -$0.21 | $15.85 |
| 2026-05-18 | 47.49% | 12.11% | -$0.21 | $15.99 |
| 2026-05-17 | 47.49% | 12.11% | -$0.21 | $15.36 |
| 2026-05-14 | 41.25% | 10.22% | -$0.21 | $15.79 |
| 2026-05-13 | 41.25% | 10.22% | -$0.21 | $15.49 |
| 2026-05-12 | 43.87% | 7.06% | -$0.23 | $15.80 |
| 2026-05-11 | 43.87% | 7.06% | -$0.23 | $15.67 |
| 2026-05-10 | 43.87% | 7.06% | -$0.23 | $18.35 |
| 2026-05-07 | 43.87% | 7.06% | -$0.23 | $19.29 |
| 2026-05-06 | 43.87% | 7.06% | -$0.23 | $18.12 |
| 2026-05-05 | 43.87% | 7.06% | -$0.23 | $17.04 |
| 2026-05-04 | 43.87% | 7.06% | -$0.23 | $16.90 |
| 2026-05-03 | 43.87% | 7.06% | -$0.23 | $17.07 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is NeuroPace Inc's next-year EPS growth estimate?▾
As of 2026-06-11, NeuroPace Inc (NPCE) has a next-year EPS growth estimate of 45.66%, based on analyst consensus.
When was the latest EPS estimate revision for NPCE?▾
The most recent revision occurred on 2026-06-09, when analysts adjusted the next-year EPS growth estimate from 47.49% to 45.66%.
What sector and industry does NeuroPace Inc belong to?▾
NeuroPace Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. NPCE appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. NeuroPace Inc (NPCE) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports